Bortezomib subcutaneous injection in combination regimens for myeloma or systemic light-chain amyloidosis: a retrospective chart review of response rates and toxicity in newly diagnosed patients. [electronic resource]
Producer: 20140507Description: 1614-20 p. digitalISSN:- 1879-114X
- Aged
- Aged, 80 and over
- Amyloidosis -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Boronic Acids -- administration & dosage
- Bortezomib
- Cyclophosphamide -- administration & dosage
- Dexamethasone -- administration & dosage
- Diarrhea -- chemically induced
- Drug Therapy, Combination
- Female
- Humans
- Injections, Subcutaneous
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Peripheral Nervous System Diseases -- chemically induced
- Pyrazines -- administration & dosage
- Retrospective Studies
- Thrombocytopenia -- chemically induced
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.